Critical New HTA Developments in Europe: Challenges & Solutions
With Prof. Dr Lieven Annemans
Course Details
THE CONTENT
European HTA systems are undergoing significant change. While national differences in methodology and decision making remain, increasing EU-level coordination is reshaping how companies must approach market access strategy.
To succeed, pharma and biotech professionals involved in market access planning need a solid grasp of the HTA landscape and how national systems are evolving alongside EU-level initiatives. This course provides a practical introduction to current HTA dynamics in Europe, helping you make sense of both the fundamentals and the latest developments.
Over the course of one day, you will gain a better understanding of the variation in HTA approaches across Europe, and how these interact with EU-level developments.
If you are looking for a concise, expert-led overview of the latest HTA trends in Europe and how they impact access planning, this course is a must-attend.
Great overall introduction to the topic, with excellent details on the challenges to be dealt with in the new legislation. The interactive aspect and engaging presentation by Prof. Dr. Lieven Annemans, an obvious expert, were particularly valuable. The course deepened my understanding of HTA and provided a comprehensive overview of the topic.
Merck
Laura Bauer, Senior Manager, Global Policy & External Affairs - Germany - June 2024
THE EXPERT
Prof. Dr Lieven Annemans is one of Europe’s most respected voices in health economics and HTA.
He has participated in over 400 health economic evaluations across 20+ countries and numerous therapeutic areas.
A long-standing expert advisor in national and EU-level HTA initiatives, with deep insight into both policy and implementation.
Academic professor, past president of ISPOR, author of "Health Economics for Non-Economists", and a widely recognised speaker and educator.
A CELforPharma faculty member since 2009, consistently praised for his engaging, pragmatic, and entertaining teaching style.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma and biotech professionals who need a clear understanding of how HTA principles, policies, and practices affect product access in Europe. It is especially valuable for executives working in:
Market Access
Pricing & Reimbursement
Medical Affairs
Health Economics
Regulatory Affairs
Marketing
The interactive format includes expert-led teaching, peer discussions, and in-depth Q&A. You will learn directly from Prof. Dr Lieven Annemans and benefit from exchanging experiences with peers facing similar access challenges across Europe.
Great lecturer; the information covered during the training was very comprehensive, addressing both the basics and the latest developments. The overview of different models used in different EU countries was extremely valuable and the participant engagement in discussions was enriching. I highly recommend this course!
Insuvia
Monika Staniulyte, Regulatory Affairs Team Lead - Lithuania - June 2024
The different types of HTAs in Europe.
How to address the broad and evolving range of assessment criteria in Europe.
How to optimise clinical evidence generation for HTA bodies.
How to use Real-World Data for HTA purposes.
How to prepare for the Joint Clinical Assessment (JCA) in the EU.
An excellent top-line overview of the practical application of health economics. The course covered a lot in a single day but remained digestible thanks to its clear format. I especially valued the discussion on current JCA developments. Peer input also added real value.
Kevin Veninga, Healthcare Communicator - The Netherlands - June 2025
| Welcome & Introductions (~15 min) |
| Definitions and Taxonomy of HTA (~1 h) |
|
| Optimising the Mix of Criteria: Challenges & Solutions (~1 h 30 min) |
|
| Generating Clinical Evidence: Challenges & Solutions (~45 min) |
|
| Lunch Break |
| The Increasing Need for Real World Data: Challenges & Solutions (~1 h 15 min) |
|
| Towards a Joint Clinical Assessment (JCA) in the EU: Challenges & Solutions (~1 h 30 min) |
|
| Summary & Final Discussion (~15 min) |
UPCOMING DATES & FORMATS - FEES
11 December 2025
Live online (CET timing)
Early bird € 1 470
(until 07/11/2025)
(Full fee € 1 670)
24 March 2026
Live online (CET timing)
Early bird € 1 570
(until 20/02/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,0/10!
Testimonials from past participants:
An excellent top-line overview of the practical application of health economics. The course covered a lot in a single day but remained digestible thanks to its clear format. I especially valued the discussion on current JCA developments. Peer input also added real value.
Kevin Veninga, Healthcare Communicator - The Netherlands - June 2025
Great overall introduction to the topic, with excellent details on the challenges to be dealt with in the new legislation. The interactive aspect and engaging presentation by Prof. Dr. Lieven Annemans, an obvious expert, were particularly valuable. The course deepened my understanding of HTA and provided a comprehensive overview of the topic.
Merck
Laura Bauer, Senior Manager, Global Policy & External Affairs - Germany - June 2024
The course and instructor were great. Lieven is clearly an expert in the field, with clear and articulate presentations. The interactions between attendees added to the experience, and I have gained valuable insights into the upcoming EU HTA changes. Highly recommended!
Novartis
Nick Riley, Senior Market Access Manager - Australia - June 2024
Great lecturer; the information covered during the training was very comprehensive, addressing both the basics and the latest developments. The overview of different models used in different EU countries was extremely valuable and the participant engagement in discussions was enriching. I highly recommend this course!
Insuvia
Monika Staniulyte, Regulatory Affairs Team Lead - Lithuania - June 2024
I got relevant information, it was refreshing also. The comparison of different countries' approaches and the excellent description of crucial parts of HTA were particularly useful. The experience from practice shared during the course enriched my understanding significantly.
Pharm-In
Dominik Grega, MA & HTA Manager - Slovakia - June 2024
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77
Course Details
Upcoming Session
11 December 2025, Live online (CET timing)
Early bird € 1 470
(until 07/11/2025)
(Full fee € 1 670)
Prices are excl. VAT
THE CONTENT
European HTA systems are undergoing significant change. While national differences in methodology and decision making remain, increasing EU-level coordination is reshaping how companies must approach market access strategy.
To succeed, pharma and biotech professionals involved in market access planning need a solid grasp of the HTA landscape and how national systems are evolving alongside EU-level initiatives. This course provides a practical introduction to current HTA dynamics in Europe, helping you make sense of both the fundamentals and the latest developments.
Over the course of one day, you will gain a better understanding of the variation in HTA approaches across Europe, and how these interact with EU-level developments.
If you are looking for a concise, expert-led overview of the latest HTA trends in Europe and how they impact access planning, this course is a must-attend.
Great overall introduction to the topic, with excellent details on the challenges to be dealt with in the new legislation. The interactive aspect and engaging presentation by Prof. Dr. Lieven Annemans, an obvious expert, were particularly valuable. The course deepened my understanding of HTA and provided a comprehensive overview of the topic.
Merck
Laura Bauer, Senior Manager, Global Policy & External Affairs - Germany - June 2024
THE EXPERT
Prof. Dr Lieven Annemans is one of Europe’s most respected voices in health economics and HTA.
He has participated in over 400 health economic evaluations across 20+ countries and numerous therapeutic areas.
A long-standing expert advisor in national and EU-level HTA initiatives, with deep insight into both policy and implementation.
Academic professor, past president of ISPOR, author of "Health Economics for Non-Economists", and a widely recognised speaker and educator.
A CELforPharma faculty member since 2009, consistently praised for his engaging, pragmatic, and entertaining teaching style.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma and biotech professionals who need a clear understanding of how HTA principles, policies, and practices affect product access in Europe. It is especially valuable for executives working in:
Market Access
Pricing & Reimbursement
Medical Affairs
Health Economics
Regulatory Affairs
Marketing
The interactive format includes expert-led teaching, peer discussions, and in-depth Q&A. You will learn directly from Prof. Dr Lieven Annemans and benefit from exchanging experiences with peers facing similar access challenges across Europe.
Great lecturer; the information covered during the training was very comprehensive, addressing both the basics and the latest developments. The overview of different models used in different EU countries was extremely valuable and the participant engagement in discussions was enriching. I highly recommend this course!
Insuvia
Monika Staniulyte, Regulatory Affairs Team Lead - Lithuania - June 2024
The different types of HTAs in Europe.
How to address the broad and evolving range of assessment criteria in Europe.
How to optimise clinical evidence generation for HTA bodies.
How to use Real-World Data for HTA purposes.
How to prepare for the Joint Clinical Assessment (JCA) in the EU.
An excellent top-line overview of the practical application of health economics. The course covered a lot in a single day but remained digestible thanks to its clear format. I especially valued the discussion on current JCA developments. Peer input also added real value.
Kevin Veninga, Healthcare Communicator - The Netherlands - June 2025
| Welcome & Introductions (~15 min) |
| Definitions and Taxonomy of HTA (~1 h) |
|
| Optimising the Mix of Criteria: Challenges & Solutions (~1 h 30 min) |
|
| Generating Clinical Evidence: Challenges & Solutions (~45 min) |
|
| Lunch Break |
| The Increasing Need for Real World Data: Challenges & Solutions (~1 h 15 min) |
|
| Towards a Joint Clinical Assessment (JCA) in the EU: Challenges & Solutions (~1 h 30 min) |
|
| Summary & Final Discussion (~15 min) |
UPCOMING DATES & FORMATS - FEES
11 December 2025
Live online (CET timing)
Early bird € 1 470
(until 07/11/2025)
(Full fee € 1 670)
24 March 2026
Live online (CET timing)
Early bird € 1 570
(until 20/02/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,0/10!
Testimonials from past participants:
An excellent top-line overview of the practical application of health economics. The course covered a lot in a single day but remained digestible thanks to its clear format. I especially valued the discussion on current JCA developments. Peer input also added real value.
Kevin Veninga, Healthcare Communicator - The Netherlands - June 2025
Great overall introduction to the topic, with excellent details on the challenges to be dealt with in the new legislation. The interactive aspect and engaging presentation by Prof. Dr. Lieven Annemans, an obvious expert, were particularly valuable. The course deepened my understanding of HTA and provided a comprehensive overview of the topic.
Merck
Laura Bauer, Senior Manager, Global Policy & External Affairs - Germany - June 2024
The course and instructor were great. Lieven is clearly an expert in the field, with clear and articulate presentations. The interactions between attendees added to the experience, and I have gained valuable insights into the upcoming EU HTA changes. Highly recommended!
Novartis
Nick Riley, Senior Market Access Manager - Australia - June 2024
Great lecturer; the information covered during the training was very comprehensive, addressing both the basics and the latest developments. The overview of different models used in different EU countries was extremely valuable and the participant engagement in discussions was enriching. I highly recommend this course!
Insuvia
Monika Staniulyte, Regulatory Affairs Team Lead - Lithuania - June 2024
I got relevant information, it was refreshing also. The comparison of different countries' approaches and the excellent description of crucial parts of HTA were particularly useful. The experience from practice shared during the course enriched my understanding significantly.
Pharm-In
Dominik Grega, MA & HTA Manager - Slovakia - June 2024
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77